KLK3 and prostate carcinoma: Organized prostate cancer screening for asymptomatic individuals using the prostate-specific antigen test is not recommended in Canada.22 Because prostate-specific antigen testing is not standardized, the actual practice is variable, which leads to unstable incidence of prostate cancer diagnosis and varying rates of overdiagnosis.